Xin Huang

6PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 17, 2024
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.

Nicholas Robert, Connie Chen, Sindy Kim

|Aug 09, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.

Georg Pfeiler, Dominik Hlauschek, Erica L Mayer

|Mar 27, 2023
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

Manuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim

|Aug 16, 2022
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.

Zhou Zhu, Nicholas C Turner, Sherene Loi

|May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.

Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im

|Feb 26, 2021
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Jee Hyun Kim, Seock Ah Im, Sung Hoon Sim

Pageof 1

Frequent Collaborators

2 joint publications

Seock-Ah Im

2 joint publications

Sibylle Loibl

2 joint publications

Massimo Cristofanilli

2 joint publications

Hiroji Iwata